Preclinical Toxicology

Jubilant Laboratory is AAALAC-accredited and has been providing pre-clinical toxicology services to many clients across the globe. Jubilant Biosys offers a large array of GLP and non-GLP preclinical toxicology studies to its customers. The studies, in which our toxicology services team has expertise comprise acute, sub-acute, and sub-chronic toxicokinetic studies in various test systems with different routes of administration, along with in vitro and in-vivo genotoxicity studies. These studies are performed in compliance with global regulatory guidelines (ICH, OECD, etc.) at Jubilant’s GLP-certified toxicology lab in India. The team consists of toxicologist certified by Diplomate of the American Board of Toxicology (DABT), European registered toxicologist (ERT) and pathologist by the Indian Board of Toxicologic Pathology (DIBTP).

We provide a comprehensive range of toxicology and safety pharmacology services in accordance with international regulatory guidelines. With routine screening of compounds in the R&D phase, we assist in toxicological safety assessment to identify and eliminate the unsafe elements at the earliest stage in drug development.

Jubilant Biosys has the latest facilities to evaluate the candidate compounds in a professional manner that results in the timely delivery of the reports. The rich experience of our scientific team helps our customers meet their specific preclinical and other early-stage product development needs, enhance their decision-making process, and save time and resources.

We offer Stand Alone Pathology Services (tissue processing through slide evaluation and reporting) for the in-life phase of toxicology and efficacy studies conducted elsewhere.